While some older weight loss medications have available generics, making them more affordable, the newer drugs can come with a hefty price tag
Petersen N, Reimann F, van Es JH, van den Berg BM, Kroone C, Pais R, et al
Ready to explore whether GLP-1 therapy is right for you
PlexusDx supports patients seeking GLP-1 access by offering compounded options at predictable costs and providing genetic context about individual peptide pathway predispositions that may help facilitate more informed conversations with healthcare providers
The combination of adequate B12 with microdose tirzepatide supports the neurological aspects of longevity protocols specifically
The first readout, TRIUMPH-1 (obesity), was reported on 21 May 2026, with 28.3% mean weight loss at 80 weeks in the 12mg cohort (Pharmaceutical Journal)